ClinicalTrials.gg
Not yet recruitingNCT06047652e-CPDUpdated Sep 21, 2023

Development of Electronic Continuing Professional Development for Indonesian Clinical Nurses

An interventional study of e-CPD user testing in Nurse's Role, sponsored by Universitas Muhammadiyah Yogyakarta. Not yet recruiting. Per ClinicalTrials.gov, last updated 2023-09-21.

Sponsored by Universitas Muhammadiyah Yogyakarta · Not applicable, Interventional, and Device feasibility

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2023, 3 years ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
7
Allocation
Not applicable
Sex
All
01

Study summary

The goal of this clinical trial is to test a e-CPD prototype device for feasibility as it is applied within the clinical nursing setting in Level II clinical nurses in Indonesia. The main questions it aims to answer are:

  • What are the user needs for clinical nurse e-CDP development?
  • How is an instructional design developed for the development of e-CPD for clinical nurses?
  • What is the most suitable e-CPD format for clinical nurses?
  • How is the feasibility of e-CPD prototype?
Read the detailed description

This research is an exploratory action research. This design is principally exploratory research (plan to explore - explore - analyse, and reflect) followed by action research (plan to change - act - observe - reflect)

  1. Exploration

    This stage includes the plan to explore stage or stage 1 of 7 research stages. This stage prepares before collecting data. Researchers will start by building good interpersonal relationships with participants and the research environment. A good relationship can also create trust to improve the quality of the data collected. At this stage, researchers also compiled interview guidelines for 3 groups of participants.

    The next stage is exploring, which is stage 2 of the 7 stages of existing research. This stage conducts data collection through FGD to 3 groups of participants. The explanation of the implementation of the FGD is as follows:

    FGD on nurses will be conducted on 8-10 nurses who have performed CPD and have followed the credentials carried out by the hospital. The purpose of this FGD with nurses is to explore understanding, experience, obstacles, efforts made to overcome obstacles, and expectations on the implementation of CPD.

    FGD on hospital management will be conducted on 8-10 hospital managers who had a role in the implementation of nurse CPD. The interview explores hospitals' management, policies, barriers, and efforts in implementing nurse CPD. Interviews with hospital management were conducted simultaneously at almost the same time as the nurse's FGD.

    FGD on the Indonesian Nurses Association committee will be conducted on 8-10 committee members who have direct authority in the implementation of CPD. The FGD focuses on the policies, barriers, and efforts that professional organizations make on nurse CPD.

    The analysis and reflect stage or stage 3 of the 7 stages of this research will be carried out by analysing the results of the FGD. These results will used as a basis for determining strategic issues and potential solutions to the problems in this study.

    The interview will be conducted by 2 people, namely researchers and research assistants. Verbatim transcripts will be performed immediately after the interview is conducted by research assistants who follow the course of the interview.

  2. Action

This stage will begin with the plan to change, the 4th stage of 7 stages of research. This stage aims to draw up an instructional design that will form the basis for the development of the e-CPD system. Activities will be carried out with a series of workshops 2 times to get mutual agreement. The workshop will be attended by nurse managers, The Indonesian Nurses Association representatives, clinical nurse assessors, and nurses in charge of care. The results of stage 4 will produce the Clinical Nurse II Competency Training Curriculum. At this stage, an expert review is also carried out to assess the suitability of the module preparation with existing provisions. Expert reviews will also be conducted to ensure that the curriculum has met the established rules. At this stage, researchers identify the ability of clinical nurses as the primary users, required features, learning media, assignments and assessments set.

The next stage is act, which is stage 5 of the 7 stages of research. This stage will carried out through the development of the e-CPD system. Researchers, in collaboration with IT professionals, will develop an e-CPD system designed to be able to facilitate the learning process as well as evaluation according to the curriculum that has been compiled. At this stage, the e-CPD system is also reviewed by the same experts who provide curriculum reviews. This is done so that the e-CPD system is built in accordance with the curriculum that has been prepared.

The observation stage, stage 6 of the 7 existing research stages, will carry out user testing. User testing aims to test the functionality of the e-CPD design that has been developed. User testing was carried out on 10 nurses who will become users of this system with the criteria: level I clinical nurses who work in hospitals, have gadgets and are willing to participate in the e-CPD system trial. The instruments used use the System Usability Scale (SUS). Participants will be asked to access and try all the features of the e-CPD application. Then, participants will be asked to complete an SUS questionnaire containing 10 questions through Google Forms. This questionnaire contains ease of access and possible use for these participants.

Reflect stage, is the last stage, stage 7 of the 7. At this stage, analysis and evaluation of the entire study that has been carried out and determine follow-up.

02

Conditions studied

  • Nurse's Role

Keywords

  • exploratory action research
  • electronic learning
  • continuing professional development
  • protocol
  • nurse
03

In context

Lead sponsor

Universitas Muhammadiyah Yogyakarta is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Level I clinical nurses who works in hospital
  • Have a mobile device
  • Willing to take e-CPD user testing

Exclusion criteria

Exclusion Criteria:

  • Did not complete the user testing
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
7 participants (estimated)

Study arms

  • Experimental
    Intervention group

    The e-CPD device will be given to the participant group according to the criteria. Each participant is given access rights for 1 week to try all the features in e-CPD.

    Device: e-CPD user testing

Interventions

  • Devicee-CPD user testing

    nurses who meet the criteria will carry out user testing on the e-CPD application via a mobile device. after accessing the e-CPD system the nurse will fill in the System Usability Scale instrument.

06

What researchers measure

Primary outcomes

  1. evaluating usability of e-CPD system, using System Usability Scale (SUS) instrumen, and Data will be collected using a Google form link given to participants after trying all the features in the e-CPD system.

    SUS has 10 questions and 5 answer choices. Answer choices range from strongly disagree to strongly agree. SUS has a minimum score of 0 and a maximum score of 100. After the calculation is carried out, the assessment results will be obtained. SUS assessment guidelines are as follow the acceptable score is approximately above 70 (above our average of 68), and the unacceptable score is below 50 (closely corresponding to our classification of scores below 51.6). They evaluated the range between 50 and 70 to be "marginally acceptable,"

    Time frame: Through study completion, an average of 3 months

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2023; primary completion for Nov 2023, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2023
First posted
Sep 21, 2023
StartEst.
Sep 2023
Primary completionEst.
Nov 2023
CompletionEst.
Dec 2023
Last update
Sep 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06047652
Lead sponsor
Universitas Muhammadiyah Yogyakarta
Responsible party
Novita Kurnia Sari (Assistant Professor, Universitas Muhammadiyah Yogyakarta) — Principal investigator
First posted
Sep 21, 2023
Start date
Sep 2023 (estimated)
Primary completion
Nov 2023 (estimated)
Completion
Dec 2023 (estimated)
Last update
Sep 21, 2023

Study contacts

Novita K Sari, Master
Contact
novita.kurniasari@umy.ac.id
+6281328066086

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion